Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma
- 1 December 2001
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 54 (12) , 951-955
- https://doi.org/10.1136/jcp.54.12.951
Abstract
The use of the H score (involving the assessment of intensity and distribution of positivity) on sections stained for the oestrogen receptor (ER) by immunocytochemistry (ICC) allows different samples to be compared and detailed correlations to be made between hormone receptor expression and morphology. This study assessed the reliability of core biopsy in predicting ER expression in the same tumour excised later at treatment. The distribution of ER within excised tumours was investigated. The distribution of ER positivity was investigated in 51 diagnostic core biopsies and across the diameter of 51 subsequently excised tumours in a field by field (magnification, x40; field diameter, 0.4 mm) assessment using the semiquantitive H scoring system. The ER H score in diagnostic core biopsy was significantly higher (p = 0.05, paired rank test; overall mean, 130; n = 51) than the mean in the corresponding excised tumour (mean, 110; n = 51). There was a significant downward trend in ER positivity from the periphery of tumours towards the centre (p = 0.001). The reduction of ER positivity was 6 H score units (2%)/mm. If core biopsies were orientated with the tumour edge at one end no change in ER positivity with field number along the length of the core could be demonstrated. ER estimation in core biopsies correlated well with expression in tumours but ER expression was higher in the core biopsies than in the excised tumours. ER expression was higher at the periphery of tumours than at the centre. The higher ER expression in cores may reflect the higher chance of sampling the peripheral part of a tumour using a needle core.Keywords
This publication has 16 references indexed in Scilit:
- Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas.2000
- Estrogen and Progesterone Receptor Contents in ThinPrep-Processed Fine-Needle Aspirates of BreastAmerican Journal of Clinical Pathology, 1999
- Imprint cytology in immunocytochemical analysis of oestrogen and progesterone receptors of breast carcinoma.Journal of Clinical Pathology, 1989
- Estrogen Receptor Enzyme Immunoassay in Fine-Needle Aspirates from Human Breast CancerActa Oncologica, 1989
- ESTROGEN-RECEPTOR ANALYSES - CORRELATION OF BIOCHEMICAL AND IMMUNOHISTOCHEMICAL METHODS USING MONOCLONAL ANTIRECEPTOR ANTIBODIES1985
- Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptorEuropean Journal of Cancer and Clinical Oncology, 1984
- Estrogen receptor assay on breast cancer microsamples: Implications of percent carcinoma estimationCancer, 1982
- Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancerCancer, 1980
- Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinomaPublished by Elsevier ,1980
- Reproducibility of measurements of oestrogen-receptor concentration in breast cancerBritish Journal of Cancer, 1977